Inmune Bio Inc

DEF 14A 1 ea0206961-01.htm PROXY STATEMENT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Check the appropriate box:

INMUNE BIO INC.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

INMUNE BIO INC.

225 NE Mizner Blvd, Suite 640, Boca Raton, FL 33432

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD JULY 19, 2024

10:00 A.M. EASTERN TIME

TO THE STOCKHOLDERS OF INMUNE BIO INC.:

The annual meeting of stockholders (the “Meeting”) of INmune Bio Inc. (which we refer to as “INmune” or the “Company”) will be a completely virtual meeting of stockholders.

To participate, vote, or submit questions 15 minutes before and duringthe Meeting via live webcast, please visit www.virtualshareholdermeeting.com/INMB2024There will not be a physical location for the Meeting.

At the Meeting, the holders of the Company’s outstanding capital stock will act on the following matters:

1. To elect six directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified; and

2. To ratify the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024.

We also will transact such other business as may properly come before the Meeting and any adjournments or postponements of the Meeting.

These matters are more fully described in the proxy statement accompanying this notice.

Only holders of the Company’s common stock of record at the close of business on May 23, 2024, are entitled to notice of and to vote at the Meeting. A proxy statement containing important information about the Meeting and the matters being voted upon appears on the following pages.

The Board of Directors recommends that you vote “FOR” the proposals set forth in this Notice of Annual Meeting of Stockholders and the Proxy Statement.

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING

The Company has enclosed a copy of the proxy statement, the proxy card and the Company’s annual report, as amended to stockholders for the year ended December 31, 2023 (the “Annual Report”). The proxy statement, the proxy card and the Annual Report are also available on the Company’s website athttps://www.inmunebio.com/index.php/en/investors/filings.

If you have any questions or need assistance voting your shares of our common stock, please contact the Company at (858) 964-3720.

BY ORDER OF THE BOARD OF DIRECTORS

/s/ David Moss

David Moss

Secretary

Boca Raton, FL

May 29, 2024

PLEASE NOTE: The Meeting will be held to tabulate the votes cast and to report the results of voting on the items described above. No other business matters are planned for the Meeting.